Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
44 40 Search
2025
The Role of Gut Microbiota in the Development and Treatment of Obesity and Overweight: A Literature Review
Journal of Clinical Medicine
2025
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives
International Journal of Molecular Sciences
2025
Differential effects of liraglutide naltrexone/bupropion, and caloric restriction on metabolic parameters and beta-cell regeneration in type 2 diabetic rat model: role of beta arrestin 1
Journal of Molecular Histology
2025
Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Gut Microbes
2025
Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
Circulation Research
2025
Anorexigenic and anti-inflammatory signaling pathways of semaglutide via the microbiota–gut––brain axis in obese mice
Inflammopharmacology
2025
Diabetes and gut microbiome
Frontiers in Microbiology
2025
Nourishing the Microbiome: Exploring the influence of Food Inflammatory Index on Gut Bacteria in Type 2 Diabetics in Saudi Arabia
F1000Research
2025
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
JHEP Reports
2024
Cistanche deserticola improves postmenopausal osteoporosis through gut microbiota and short-chain fatty acids
Journal of Functional Foods
2024
Mendelian randomization analysis reveals a causal effect of Streptococcus salivarius on diabetic retinopathy through regulating host fasting glucose
Journal of Cellular and Molecular Medicine
2024
Gut microbiota and therapy for obesity and type 2 diabetes
Frontiers in Endocrinology
2024
Microbiote intestinal et diabète de type 2 : perspectives thérapeutiques
Pratiques en nutrition
2024
Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-Oxoproline
European Journal of Pharmacology
2023
Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
Frontiers in Cellular and Infection Microbiology
2023
Drug-microbiota interactions: an emerging priority for precision medicine
Signal Transduction and Targeted Therapy
2023
Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies
Biomedicine & Pharmacotherapy
2023
Glucagon‐like peptide‐1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism
MedComm
2023
From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes
Biomedicines
2023
Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
Life
2023
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
Inflammopharmacology
2023
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Cell Metabolism
2023
Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus
mSystems
2023
Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review
Genes
2023
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment
Frontiers in Endocrinology
2023
The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
International Journal of Molecular Sciences
2023
Gut microbiome profiles may be related to atypical antipsychotic associated overweight in Asian children with psychiatric disorder: a preliminary study
Frontiers in Cellular and Infection Microbiology
2022
Gut Microbiota Dysbiosis in the Development and Progression of Gastric Cancer
Journal of Oncology
2022
Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
Frontiers in Endocrinology
2022
Abnormal gut microbiota and impaired incretin effect as a cause of type 2 diabetes mellitus
Medical Herald of the South of Russia
2022
Tilapia nilotica Head Lipids Improved Bone Loss by Regulating Inflammation and Serum Metabolism Through Gut Microbiota in Ovariectomized Rats
Frontiers in Nutrition
2022
Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
Frontiers in Cellular and Infection Microbiology
2022
Baihu renshen decoction ameliorates type 2 diabetes mellitus in rats through affecting gut microbiota enhancing gut permeability and inhibiting TLR4/NF-κB-mediated inflammatory response
Frontiers in Cellular and Infection Microbiology
2022
Composition and diversity of gut microbiota in diabetic retinopathy
Frontiers in Microbiology
2022
Retinal Degeneration: Molecular Mechanisms and Therapeutic Strategies
Current Medicinal Chemistry
2022
Compound dietary fiber and high-grade protein diet improves glycemic control and ameliorates diabetes and its comorbidities through remodeling the gut microbiota in mice
Frontiers in Nutrition
2022
GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Microorganisms
2022
Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes
Frontiers in Endocrinology
2022
Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance
Frontiers in Endocrinology
2021
Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products
World Journal of Diabetes
2021
Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?
Life Sciences
2021
Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy
Journal of Inflammation Research
2021
New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes
Drug Design, Development and Therapy
Additional cited-by details will be shown when available from Crossref